Scandinavian ChemoTech AB (publ)

𝐒𝐜𝐚𝐧𝐝𝐢𝐧𝐚𝐯𝐢𝐚𝐧 𝐂𝐡𝐞𝐦𝐨𝐓𝐞𝐜𝐡’𝐬 𝐀𝐧𝐢𝐦𝐚𝐥 𝐂𝐚𝐫𝐞 𝐂𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐬 𝐭𝐨 𝐆𝐫𝐨𝐰! Animal Care is closing 2024 on a high, with strong sales growth driven by the increasing adoption of the vetIQure™ TSE system. Repeat purchases from satisfied customers underline the trust and value our technology brings to veterinary practices. 𝐂𝐄𝐎 𝐌𝐨𝐡𝐚𝐧 𝐅𝐫𝐢𝐜𝐤: "Our expanding presence in the USA and Europe reflects the clinical and economic benefits of TSE technology." We’re looking forward to building on this momentum in 2025! Read the full press release here: https://lnkd.in/ddhPZAd6 Vetiqure AB #VeterinaryCare #Innovation #AnimalCare #vetIQure #Growth #medtech #animalcare #BusinessDevelopment #vettech

𝐕𝐢𝐩𝐞𝐫’𝐬 𝐕𝐢𝐜𝐭𝐨𝐫𝐲 𝐎𝐯𝐞𝐫 𝐇𝐞𝐦𝐚𝐧𝐠𝐢𝐨𝐬𝐚𝐫𝐜𝐨𝐦𝐚 𝐰𝐢𝐭𝐡 𝐓𝐒𝐄 𝐕𝐢𝐩𝐞𝐫’𝐬 𝐉𝐨𝐮𝐫𝐧𝐞𝐲 – Viper, a 7-year-old Dutch Shepherd working with a sheriff’s department, was diagnosed with a high-grade Subcutaneous Hemangiosarcoma. This aggressive cancer posed a risk to his health and active lifestyle. Viper’s veterinarian used vetIQure’s Tumor Specific Electroporation (TSE) technology to provide targeted treatment. 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐏𝐚𝐭𝐡: With TSE, Viper’s veterinarian was able to treat the tumor effectively without compromising surrounding healthy tissue. Viper’s latest checkups confirm no signs of tumor regrowth, allowing him to continue his essential work with full mobility. 𝐎𝐮𝐭𝐜𝐨𝐦𝐞: We’re proud that TSE has helped veterinarians support pets like Viper in maintaining their quality of life. His case illustrates how TSE can be a powerful tool for treating aggressive cancers without impacting a pet’s active role. #vetIQure #innovation #CancerTreatment #VeterinaryOncology #Hemangiosarcoma #VeterinaryMedicine #medtech #TumorElectroporation #veterinarymedicine #veterinary

𝐋𝐞𝐞’𝐬 𝐒𝐮𝐜𝐜𝐞𝐬𝐬 𝐰𝐢𝐭𝐡 𝐍𝐨𝐧-𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐓𝐒𝐄 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐋𝐞𝐞’𝐬 𝐂𝐚𝐬𝐞 – A 9-year-old Labrador was diagnosed with a mast cell tumor located on his eyelid, a difficult area for traditional cancer treatments. Lee’s veterinarian turned to vetiqure’s Tumor Specific Electroporation (TSE) technology as a precise, non-surgical option. 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐏𝐫𝐨𝐜𝐞𝐬𝐬: With just one TSE treatment, the tumor size reduced significantly, making surgery unnecessary. A second treatment completed the process, leaving a minimal pale scar. Lee retained his vision and eye comfort without needing invasive surgery. 𝐎𝐮𝐭𝐜𝐨𝐦𝐞: Thanks to TSE, Lee’s veterinarian achieved a successful outcome with no tumor regrowth, maintaining Lee’s eye health and quality of life. This case highlights how TSE is empowering veterinarians to tackle challenging tumors in sensitive locations. #vetiQure #TSE #VeterinaryOncology #CanineCancer #MastCellTumor #NonInvasiveTreatment #VeterinaryInnovation #innovation #cancertreatment #vettech

𝐀 𝐍𝐞𝐰 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐢𝐧 𝐄𝐪𝐮𝐢𝐧𝐞 𝐂𝐚𝐧𝐜𝐞𝐫 𝐂𝐚𝐫𝐞: 𝐕𝐞𝐭𝐢𝐪𝐮𝐫𝐞 & 𝐍𝐌𝐁𝐔 ChemoTech’s Animal Care, Vetiqure AB, is proud to announce a collaboration with the Norwegian University of Life Sciences (NMBU) Hospital for Equine Medicine. Together with Professor Cathrine Fjordbakk’s team, we are integrating Tumour Specific Electroporation (TSE) therapy into routine treatments, paving the way for safer, minimally invasive options in equine oncology. This partnership represents a meaningful advancement in veterinary oncology, combining academic expertise with innovative therapeutic solutions. With NMBU, we aim to expand the possibilities in veterinary cancer care, providing horses with safer, less invasive treatment options through TSE. https://lnkd.in/dNxtwMGx #VeterinaryOncology #AnimalCare #EquineMedicine #InnovationInHealth #TSEtherapy #ChemoTech #veterinarymedicine #innovation #medtech #Norway

𝐀𝐧𝐠𝐞𝐥’𝐬 𝐉𝐨𝐮𝐫𝐧𝐞𝐲 𝐰𝐢𝐭𝐡 𝐓𝐒𝐄 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐀𝐧𝐠𝐞𝐥’𝐬 𝐒𝐭𝐨𝐫𝐲 – An 11-year-old feline patient diagnosed with Feline Injection Site Sarcoma. Faced with a challenging cancer diagnosis, Angel’s owner wanted to avoid amputation. Fortunately, their veterinarian used vetIQure’s Tumor Specific Electroporation (TSE) technology to provide a less invasive treatment option. 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡: Angel received two TSE treatments in combination with surgery to remove the tumor with minimal risk of regrowth. Over a year later, Angel remains in complete remission with no signs of scarring or recurrence. 𝐎𝐮𝐭𝐜𝐨𝐦𝐞: Angel’s case is a great example of how veterinarians are using TSE technology to treat aggressive cancers effectively while preserving quality of life. We’re proud to support vets in offering treatments that are kinder and less invasive for pets. #vetiQure #TSE #VeterinaryOncology #FelineCancer #PetCancerCare #TumorElectroporation #InnovationInVetMed #innovation #veterinarymedicine #medtech

Danny E. Nesrallah and the Vetiqure AB team have just landed in Orlando, Florida! Join us at the VCS Annual Conference 2024, where we’ll present exciting case studies and showcase new posters from a renowned veterinary oncologist. Stay tuned for updates from the event! #vetIQure #VCS2024 #VeterinaryOncology #CaseStudies #Innovation #AnimalHealth #VetConference #OrlandoEvents #veterinarymedicin #medtech

We look forward to welcoming our honoured guests to INAUGURATE INDIA SWEDEN INNOVATION DAY 2024 on Monday, October 14th in Stockholm. Chief Guest, H.E. Dr. Jitendra Singh, Minister for Science and Technology, Ministry of Science and Technology, Government of India Chief Guest, H.E. Ebba Busch, Vice Prime Minister & Minister for Energy and Enterprise Regeringskansliet, Klimat- och näringslivsdepartementet, Government of Sweden Regeringskansliet H.E. Tanmaya Lal, Secretary West, Ministry of External Affairs, India, Government of India H.E. Jan Thesleff, Ambassador of Sweden to India, Government of Sweden Regeringskansliet Robin Sukhia, Secretary General & CEO of the Sweden-India Business Council (SIBC) / Chairman of Scandinavian ChemoTech AB (publ) Sanjoo Malhotra, CEO of India Unlimited. See the full program: https://lnkd.in/dg_raYw4 Embassy of India Stockholm, Sweden In India, Sweden-India Business Council (SIBC), Robin Sukhia, Rakesh Tiwari , Richa Soni Rai Noi Cecilia Oldne Sanjoo Malhotra Per-Arne Wikström Saloni Zaveri-Ahluwalia Sara Larsson #IndiaSwedenInnovation2024 #Collaboration #Innovation #Leadership

𝐖𝐞'𝐫𝐞 𝐒𝐭𝐢𝐥𝐥 𝐇𝐢𝐫𝐢𝐧𝐠: 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐒𝐩𝐞𝐜𝐢𝐚𝐥𝐢𝐬𝐭 Are you passionate about veterinary innovation and advanced cancer care? We are still on the lookout for a passionate and driven 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐒𝐩𝐞𝐜𝐢𝐚𝐥𝐢𝐬𝐭 to help drive our Animal Care division in Germany and Benelux! We’re seeking someone dynamic, growth-oriented, and ready to make an impact. 𝐊𝐞𝐲 𝐪𝐮𝐚𝐥𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬: ■ Sales success & growth experience ■ Strong communication and presentation skills ■ Flexibility to travel Join us on this exciting journey! 👉 𝐀𝐩𝐩𝐥𝐲 𝐧𝐨𝐰: https://lnkd.in/d7-jRtwh #Vetiqure #VeterinaryJobs #Sales #Hiring #Germany #Benelux #innovation #veterinarymedicine

𝐂𝐨𝐧𝐠𝐫𝐚𝐭𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐩𝐞𝐭 𝐨𝐰𝐧𝐞𝐫𝐬 𝐚𝐧𝐝 𝐜𝐥𝐢𝐧𝐢𝐜𝐬 𝐨𝐟 𝐂𝐨𝐥𝐨𝐫𝐚𝐝𝐨! We’re proud to announce that the innovative vetIQure™ TSE system is now available in the state, providing a safe and effective tumour treatment option that preserves healthy tissue. This unique technology ensures pets get the best care possible, offering advanced solutions for veterinary oncology. “𝑇ℎ𝑖𝑠 𝑐𝑜𝑙𝑙𝑎𝑏𝑜𝑟𝑎𝑡𝑖𝑜𝑛 𝑖𝑠 𝑎 𝑘𝑒𝑦 𝑚𝑖𝑙𝑒𝑠𝑡𝑜𝑛𝑒 𝑓𝑜𝑟 𝑜𝑢𝑟 𝑔𝑟𝑜𝑤𝑡ℎ 𝑖𝑛 𝑡ℎ𝑒 𝑈.𝑆.,” 𝑠𝑎𝑦𝑠 𝐷𝑎𝑛𝑛𝑦 𝑁𝑒𝑠𝑟𝑎𝑙𝑙𝑎ℎ, 𝐻𝑒𝑎𝑑 𝑜𝑓 𝐵𝑢𝑠𝑖𝑛𝑒𝑠𝑠 𝐷𝑒𝑣𝑒𝑙𝑜𝑝𝑚𝑒𝑛𝑡, 𝐴𝑛𝑖𝑚𝑎𝑙 𝐶𝑎𝑟𝑒 𝑈𝑆𝐴. https://lnkd.in/dM-xCmHz #vetIQure #AnimalCare #PetHealth #ChemoTech #ColoradoPets #VeterinaryCare #CancerTreatmentForPets #InnovativeVetSolutions #PetOncology #TSETechnology #AdvancedVetCare #AnimalWellness

We are #hiring! Please share and help us find our newest star to join our Animal Care Division!